Shares of Doximity, Inc. (DOCS) plummeted 14.73% during Friday's trading session, extending the sharp decline that began in pre-market trading following the release of the company's fiscal 2026 second-quarter financial results. The significant drop comes despite Doximity reporting better-than-expected Q2 performance, as investors appear to be focusing on the company's forward guidance suggesting a potential slowdown in growth.

Doximity's Q2 results were impressive, with revenue reaching $168.525 million, surpassing the estimated $156.8 million. Adjusted earnings per share (EPS) came in at $0.45, beating the consensus estimate of $0.38, while adjusted EBITDA hit $100.8 million, significantly higher than the expected $87.1 million. However, these strong figures were overshadowed by concerns about future growth prospects.

The main driver behind the stock's plunge seems to be Doximity's outlook for the third quarter and full fiscal year. The company forecasts Q3 revenue between $180 million and $181 million, which is only in line with analyst expectations rather than exceeding them. For the full fiscal year, Doximity projects revenue in the range of $640-646 million, up from previous guidance but suggesting a potential deceleration in growth. This outlook has raised concerns about the company's ability to maintain its growth trajectory. Adding to the downward pressure, Evercore ISI analyst Elizabeth Anderson lowered the firm's price target on Doximity to $70 from $81, although maintaining an Outperform rating on the shares. The sharp decline also indicates possible profit-taking, as Doximity's shares had gained nearly 20% year-to-date prior to this announcement.